Skip to content

Clinical trials

Withdrawn Phase 1/2 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Withdrawn Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20157
20162
20173
20181
20197
20201
20213
20225
20233
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou10
Children's Hospital of Fudan University2
Institute of Hematology & Blood Diseases Hospital, China2
Kunming Hope of Health Hospital2
Zhujiang Hospital2
Beijing 302 Hospital1
BioNova Pharmaceuticals (Shanghai) LTD.1
Chongqing Precision Biotech Co., Ltd1
Dizal Pharmaceuticals1
First Affiliated Hospital of Harbin Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell5
Breast Neoplasms3
Carcinoma, Hepatocellular3
Glioma3
Lung Neoplasms3
Pancreatic Neoplasms3
Burkitt Lymphoma2
Colorectal Neoplasms2
Leukemia, B-Cell2
Lymphoma2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.